Trial Profile
Effect of PTH(1-34) Treatment on Fracture Healing in Vivo.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2015
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Fracture; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 06 Nov 2012 Status changed from not yet recruiting to discontinued as reported by European Clinical Trials Database.
- 13 Sep 2008 New trial record.